---
title: Endpoints shares our FDA letter
description: We’re getting more coverage from larger outlets.
---

[APC in the News ](https://a4pc.org/inthenews)

# [Endpoints shares our FDA letter](https://a4pc.org/inthenews/2024-12/endpoints-shares-our-fda-letter)

 Written by [Andrew](https://a4pc.org/inthenews/author/andrew) | Dec 09, 2024

Adding to the list of larger news outlets covering what APC is up to is Endpoints News (from the *Financial Times*). [It wrote about our letter to the FDA](https://archive.ph/9cNg2) that pointed out that semaglutide isn’t difficult to compound, despite erroneous claims by Novo Nordisk.

[View full post](https://a4pc.org/inthenews/2024-12/endpoints-shares-our-fda-letter)

```json
{
  "@context" : "http://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "Andrew"
  },
  "dateModified" : "2025-01-29T22:35:17.291Z",
  "datePublished" : "2024-12-09T09:00:00Z",
  "headline" : "Endpoints shares our FDA letter",
  "image" : {
    "@type" : "ImageObject",
    "height" : 61,
    "url" : "https://join.a4pc.org/hubfs/endpoints-logo.png",
    "width" : 326
  },
  "mainEntityOfPage" : "https://a4pc.org/inthenews/2024-12/endpoints-shares-our-fda-letter",
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "height" : 60,
      "url" : "/hs/hsstatic/content_shared_assets/static-1.4092/img/default-amp-logo.png",
      "width" : 60
    },
    "name" : "APC in the News"
  }
}
```